Transforming growth factor beta signaling in hepatocytes participates in steatohepatitis through regulation of cell death and lipid metabolism in mice

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Hepatology

• Publication date

  2014-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/hep.26698PMID 23996730PMCID PMC3946696
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Toll‐like receptor 2 and palmitic acid cooperatively contribute to the development of nonalcoholic steatohepatitis through inflammasome activation in mice

  2013cited by this paper
• Transforming growth factor-β signaling in hepatocytes promotes hepatic fibrosis and carcinogenesis in mice with hepatocyte-specific deletion of TAK1.

  2013cited by this paper
• Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis

  2012influential reference
• p53/p66Shc-mediated signaling contributes to the progression of non-alcoholic steatohepatitis in humans and mice.

  2012cited by this paper
• Effect of Colesevelam on Liver Fat Quantified by Magnetic Resonance in Nonalcoholic Steatohepatitis: A Randomized Controlled Trial

  2012cited by this paper
• Correlation between liver histology and novel magnetic resonance imaging in adult patients with non‐alcoholic fatty liver disease – MRI accurately quantifies hepatic steatosis in NAFLD

  2012influential reference
• Secondary causes of nonalcoholic fatty liver disease

  2012cited by this paper
• Hepatic recruitment of macrophages promotes nonalcoholic steatohepatitis through CCR2.

  2012cited by this paper
• Non-alcoholic fatty liver disease: a massive problem.

  2011cited by this paper
• TGF-β in progression of liver disease

  2011cited by this paper
• Protection from obesity and diabetes by blockade of TGF-β/Smad3 signaling.

  2011influential reference
• Endpoints and clinical trial design for nonalcoholic steatohepatitis

  2011cited by this paper
• Transforming growth factor-β in the gastrointestinal and hepatic tumor microenvironment.

  2011cited by this paper
• Smad3 Deficiency in Mice Protects Against Insulin Resistance and Obesity Induced by a High-Fat Diet

  2011influential reference
• A Key Role for NOX4 in Epithelial Cell Death During Development of Lung Fibrosis

  2011cited by this paper
• Inflammatory links between obesity and metabolic disease.

  2011cited by this paper
• Nonalcoholic fatty liver disease: pathology and pathogenesis.

  2010cited by this paper
• Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice.

  2010cited by this paper
• A position statement on NAFLD/NASH based on the EASL 2009 special conference.

  2010cited by this paper
• Transforming Growth Factor-/ Smad 3 Signaling Regulates Insulin Gene Transcription and Pancreatic Islet-Cell Function *

  2009cited by this paper
• Hypotheses on the Role of Transforming Growth Factor-β in the Onset and Progression of Hepatocellular Carcinoma

  2009cited by this paper
• Antiapoptotic effect of c-Jun N-terminal Kinase-1 through Mcl-1 stabilization in TNF-induced hepatocyte apoptosis.

  2009cited by this paper
• TGF-beta enhances alcohol dependent hepatocyte damage via down-regulation of alcohol dehydrogenase I.

  2009cited by this paper
• JNK1-dependent PUMA Expression Contributes to Hepatocyte Lipoapoptosis*

  2009cited by this paper
• Role of TGF-β in proliferative vitreoretinal diseases and ROCK as a therapeutic target

  2008cited by this paper
• Reduced nicotinamide adenine dinucleotide phosphate oxidase mediates fibrotic and inflammatory effects of leptin on hepatic stellate cells

  2008cited by this paper
• An anti-transforming growth factor beta antibody suppresses metastasis via cooperative effects on multiple cell compartments.

  2008cited by this paper
• Metabolic Endotoxemia Initiates Obesity and Insulin Resistance

  2007cited by this paper
• TLR4 enhances TGF-beta signaling and hepatic fibrosis.

  2007cited by this paper
• Gastric bypass surgery improves metabolic and hepatic abnormalities associated with nonalcoholic fatty liver disease.

  2006cited by this paper
• Increased expression of Ob‐Rb and its relationship with the overexpression of TGF‐β1 and the stage of fibrosis in patients with nonalcoholic steatohepatitis

  2006cited by this paper
• TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo.

  2005cited by this paper
• Essential function for the kinase TAK1 in innate and adaptive immune responses

  2005cited by this paper
• Liver fibrosis.

  2005cited by this paper
• Design and validation of a histological scoring system for nonalcoholic fatty liver disease

  2005cited by this paper
• Erratum: Liver fibrosis (Journal of Clinical Investigation (2005) 115 (209-218) DOI:10.1172/JCI200524282)

  2005cited by this paper
• Liver fibrosis

  2004cited by this paper
• Therapeutic role of TGF-beta-neutralizing antibody in mouse cyclosporin A nephropathy: morphologic improvement associated with functional preservation.

  2003cited by this paper
• A Resorcylic Acid Lactone, 5Z-7-Oxozeaenol, Prevents Inflammation by Inhibiting the Catalytic Activity of TAK1 MAPK Kinase Kinase*

  2003cited by this paper
• Roles of TGF-beta in hepatic fibrosis.

  2002cited by this paper

• Lisosan G as a Modulator of Serum Lipid/Lipoprotein Changes, Lipid Metabolism and TGF-β1 Level in Neoplastic and Non-Neoplastic Liver Injury: A Rat Model Study

  2026cites this paper
• Exploring the prediction model and core genes for coronary artery disease in non-obese steatotic liver disease patients.

  2026cites this paper
• Characterizing hub biomarkers for metabolic-induced endothelial dysfunction and unveiling their regulatory roles in EndMT through RNA sequencing and machine learning approaches

  2025cites this paper
• Dual signaling pathways of TGF-β superfamily cytokines in hepatocytes: balancing liver homeostasis and disease progression

  2025cites this paper
• Sex differences in diet-induced MASLD – are female mice naturally protected?

  2025cites this paper
• TGF-β3-mediated phagocytosis protects mammary epithelial cells of ketotic dairy cows against metabolic stress-induced inflammatory damage.

  2025cites this paper
• Transforming Growth Factor-β Signaling in Alcohol-Associated Liver Disease

  2025cites this paper
• The role of hepatic sinusoidal microenvironment in NASH: pathogenesis, animal models, and therapeutic prospects

  2025cites this paper
• CHIP mediates glucagon action on hepatic glucose production via regulating Smad3 ubiquitination

  2025cites this paper
• Obesity-Driven Metabolic Disorders: The Interplay of Inflammation and Mitochondrial Dysfunction

  2025cites this paper
• Endocrine and metabolic drivers of sebum dysregulation: Mechanisms and therapeutic strategies.

  2025cites this paper
• New insights into therapeutic strategies for targeting hepatic macrophages to alleviate liver fibrosis.

  2025cites this paper
• Oxidative Stress Mediates the Dual Regulatory Effects of Bovine Uterine ECM Remodeling Through the TGF-β1/Smad3 Pathway: Molecular Mechanisms of MMPs and COL-IV Imbalances

  2025cites this paper
• Recent advances in targeting obesity, with a focus on TGF-β signaling and vagus nerve innervation

  2025influential citation
• Palmitic acid induced the onset of lipotoxicity in a HepaSH-on-chip model with raised of H2O2 and IL-6, and altered p38/MAPK & JAK/STAT pathways.

  2025cites this paper
• ATF4 drives regulatory T cell functional specification in homeostasis and obesity.

  2025cites this paper
• Intermittent fasting alleviates high-fat-diet-induced fatty liver disease via TGF-β1 and MMP-9 regulation in albino rats

  2025cites this paper
• Extracellular Vesicles from Escherichia coli Strains of the Gut Microbiota Trigger Hepatic Antioxidant and Anti-Lipogenic Effects via the Gut-Liver Axis in Healthy Neonatal Rats

  2025cites this paper
• Multi-Omic Characterization of Epithelial–Mesenchymal Transition: Lipidomic and Metabolomic Profiles as Key Markers of TGF-β-Induced Transition in Huh7 Hepatocellular Carcinoma

  2025cites this paper
• Extracellular vesicle-dependent crosstalk between hepatic stellate cells and Kupffer cells promotes their mutual activation.

  2025cites this paper
• The Non‐Canonical ChREBPα Activity Suppresses the Activation of Hepatic Stellate Cells and Liver Fibrosis by Antagonizing TGF‐β‐E2F1 Axis

  2025cites this paper
• Metabolic Dysfunction of Adipocytes Promotes the Secretion of Inflammatory TGFβ with Pro-Migratory Activity in Pancreatic Cancer

  2025cites this paper
• Oxy210 Inhibits Hepatic Expression of Senescence-Associated, Pro-Fibrotic, and Pro-Inflammatory Genes in Mice During Development of MASH and in Hepatocytes In Vitro

  2025cites this paper
• Morphological changes and gene mRNA expression level Ptgs2, Tgfb1 in rats liver with glutamate-induced obesity and correction with the multiprobiotic «Symbiter acidophilic» concentrated

  2025cites this paper
• Oroxyloside Inhibits Liver Fibrosis and Hepatocarcinogenesis Dependent on Hepatocyte-Specific Knockout of Atg5

  2025cites this paper
• A Novel TGFβ Receptor Inhibitor, IPW-5371, Prevents Diet-induced Hepatic Steatosis and Insulin Resistance in Irradiated Mice

  2024cites this paper
• Hepatic regulator of G protein signaling 14 ameliorates NAFLD through activating cAMP-AMPK signaling by targeting Giα1/3

  2024cites this paper
• TRAF2 decrease promotes the TGF‐β‐mTORC1 signal in MAFLD‐HCC through enhancing AXIN1‐mediated Smad7 degradation

  2024influential citation
• Integrated Lipidomic and transcriptomics to explore the effects of ethyl acetate extract of Herpetospermum pedunculosum on nonalcoholic fatty liver disease in mice.

  2024cites this paper
• LHPP deficiency aggravates liver fibrosis through TGF‐β/Smad3 signaling

  2024cites this paper
• Aldehydes alter TGF-β signaling and induce obesity and cancer

  2024cites this paper
• Hepatocyte programmed cell death: the trigger for inflammation and fibrosis in metabolic dysfunction-associated steatohepatitis

  2024cites this paper
• High-fat and high-carbohydrate diets increase bone fragility through TGF-β–dependent control of osteocyte function

  2024cites this paper
• Melatonin mitigated methotrexate-induced hepatotoxicity through interrelated biological processes

  2024cites this paper
• Anti-hepatitis B Virus Treatment with Tenofovir Amibufenamide Has No Impact on Blood Lipids: A Real-world, Prospective, 48-week Follow-up Study

  2024cites this paper
• Quercetin prevents rats from type 1 diabetic liver damage by inhibiting TGF-ꞵ/apelin gene expression

  2024cites this paper
• The Effect of Barley Bran Polyphenol-Rich Extracts on the Development of Nonalcoholic Steatohepatitis in Sprague–Dawley Rats Fed a High-Fat and High-Cholesterol Diet

  2024cites this paper
• Resveratrol Alleviates Liver Fibrosis Induced by Long-Term Inorganic Mercury Exposure through Activating the Sirt1/PGC-1α Signaling Pathway.

  2024cites this paper
• Hepatocellular Interactions of Potential Nutraceuticals in the Management of Inflammatory NAFLD

  2024cites this paper
• Exosome prospects in the diagnosis and treatment of non-alcoholic fatty liver disease

  2024cites this paper
• Association between cardiometabolic index and all-cause and cause-specific mortality among the general population: NHANES 1999–2018

  2024cites this paper
• Effects of laparoscopic sleeve gastrectomy on nonalcoholic fatty liver disease and TGF-β signaling pathway.

  2023cites this paper
• Anti-miR-96 and Hh pathway inhibitor MDB5 synergistically ameliorate alcohol-associated liver injury in mice.

  2023cites this paper
• Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH)

  2023cites this paper
• Comprehensive Strategy for Identifying Extracellular Vesicle Surface Proteins as Biomarkers for Non-Alcoholic Fatty Liver Disease

  2023cites this paper
• Pirfenidone ameliorates liver steatosis by targeting the STAT3-SCD1 axis

  2023cites this paper
• Liposomal Silybin Improves Glucose and Lipid Metabolisms in Type 2 Diabetes Mellitus Complicated with Non-Alcoholic Fatty Liver Disease via AMPK/TGF-β1/Smad Signaling.

  2023cites this paper
• The Role of CTGF in Liver Fibrosis Induced in 3D Human Liver Spheroids

  2023cites this paper
• Microbiome Dysbiosis: A Pathological Mechanism at the Intersection of Obesity and Glaucoma

  2023cites this paper
• Ablation of the deubiquitinase USP15 ameliorates nonalcoholic fatty liver disease and nonalcoholic steatohepatitis

  2023cites this paper
• Downregulation of fatty acid oxidation led by Hilpda increases G2/M arrest/delay-induced kidney fibrosis.

  2023cites this paper
• Overview of Cellular and Soluble Mediators in Systemic Inflammation Associated with Non-Alcoholic Fatty Liver Disease

  2023cites this paper
• Transforming growth factor- β mediated regulation of epigenome is required for epithelial to mesenchymal transition associated features in liver cancer cells.

  2023cites this paper
• Global trends and hotspots of treatment for nonalcoholic fatty liver disease: A bibliometric and visualization analysis (2010-2023)

  2023cites this paper
• TCDD dysregulation of lncRNA expression, liver zonation and intercellular communication across the liver lobule

  2023cites this paper
• Loss of EGFR contributes to high‐fat diet‐induced nonalcoholic fatty liver disease

  2023cites this paper
• TCDD dysregulation of lncRNA expression, liver zonation and intercellular communication across the liver lobule.

  2023cites this paper
• Zinc Improves Semen Parameters in High-Fat Diet-Induced Male Rats by Regulating the Expression of LncRNA in Testis Tissue

  2023cites this paper
• Lipid Metabolic Disorders in Neurodegenerative Diseases – Role of Androgen Receptor

  2023cites this paper
• Transcription factor Foxo1 mediates TGF-β1-induced apoptosis in hepatocytes.

  2023cites this paper
• miR-12135 ameliorates liver fibrosis accompanied with the downregulation of integrin subunit alpha 11

  2023cites this paper
• Transforming growth factor‐beta 1: A new factor reducing hepatic SHBG production in liver fibrosis

  2022cites this paper
• MicroRNA global profiling in cystic fibrosis cell lines reveals dysregulated pathways related with inflammation, cancer, growth, glucose and lipid metabolism, and fertility: an exploratory study

  2022cites this paper
• Shenkang Injection for Treating Renal Fibrosis-Metabonomics and Regulation of E3 Ubiquitin Ligase Smurfs on TGF-β/Smads Signal Transduction

  2022cites this paper
• Chronic Inflammation—A Link between Nonalcoholic Fatty Liver Disease (NAFLD) and Dysfunctional Adipose Tissue

  2022cites this paper
• IL-6 inhibitors effectively reverse post-infarction cardiac injury and ischemic myocardial remodeling via the TGF-β1/Smad3 signaling pathway

  2022cites this paper
• Hepatoprotection of Probiotics Against Non-Alcoholic Fatty Liver Disease in vivo: A Systematic Review

  2022cites this paper
• Pharmacological systemic analysis of gardenia fructus against non-alcoholic fatty liver disease and validation of animal models

  2022cites this paper
• Impaired reciprocal regulation between SIRT6 and TGF‐β signaling in fatty liver

  2022cites this paper
• Developmental modeling of hepatogenesis using obese iPSCs-hepatocyte differentiation uncovers pathological features

  2022cites this paper
• Long non-coding RNA GAS5 contributes to the progression of nonalcoholic fatty liver disease by targeting the microRNA-29a-3p/NOTCH2 axis

  2022cites this paper
• The Interplay Between TGF-β Signaling and Cell Metabolism

  2022cites this paper
• Oxidized corn oil changes the liver lipid metabolism of broilers by upregulating peroxisome proliferators activate receptor-α

  2022cites this paper
• Loss of ERdj5 exacerbates oxidative stress in mice with alcoholic liver disease via suppressing Nrf2.

  2022cites this paper
• The effects of voluntary wheel running during weight-loss on biomarkers of hepatic lipid metabolism and inflammation in C57Bl/6J mice

  2022cites this paper
• Mapping Proteome and Lipidome Changes in Early-Onset Non-Alcoholic Fatty Liver Disease Using Hepatic 3D Spheroids

  2022cites this paper
• The potential of mecciRNA in hepatic stellate cell to regulate progression of nonalcoholic hepatitis

  2022cites this paper
• Established new compound IMB16-4 self-emulsifying drug delivery systems for increasing oral bioavailability and enhancing anti-hepatic fibrosis effect.

  2022cites this paper
• Inflammasome-Mediated Cytokines: A Key Connection between Obesity-Associated NASH and Liver Cancer Progression

  2022cites this paper
• The role of hepatic microenvironment in hepatic fibrosis development

  2022cites this paper
• Non-Alcoholic Steatohepatitis (NASH) and Organokines: What Is Now and What Will Be in the Future

  2022cites this paper
• The mitochondrial NAD kinase functions as a major metabolic regulator upon increased energy demand

  2022cites this paper
• Hepatocyte-specific Prominin-1 protects against liver injury-induced fibrosis by stabilizing SMAD7

  2022cites this paper
• Hepatocyte TGF‐β Signaling Inhibiting WAT Browning to Promote NAFLD and Obesity Is Associated With Let‐7b‐5p

  2022influential citation
• Losartan ameliorates renal interstitial fibrosis through metabolic pathway and Smurfs-TGF-β/Smad.

  2022cites this paper
• Tanshinone IIA Ameliorates Nonalcoholic Steatohepatitis in Mice by Modulating Neutrophil Extracellular Traps and Hepatocyte Apoptosis

  2022cites this paper
• Intercellular communication among liver cells in the perisinusoidal space of the injured liver: Pathophysiology and therapeutic directions

  2022cites this paper
• Targeting fatty acid metabolism for fibrotic disorders

  2021cites this paper
• Liver Fibrosis and MAFLD: From Molecular Aspects to Novel Pharmacological Strategies

  2021cites this paper
• TAK1: A Molecular Link Between Liver Inflammation, Fibrosis, Steatosis, and Carcinogenesis

  2021cites this paper
• LRG1 is an adipokine that mediates obesity-induced hepatosteatosis and insulin resistance.

  2021cites this paper
• Analysis of miRNAs Profiles in Serum of Patients With Steatosis and Steatohepatitis

  2021cites this paper
• Indicios de fibrogénesis en hígado esteatósico no alcohólico de pacientes con componentes del síndrome metabólico

  2021cites this paper
• Mesenchymal stem cell-secreted prostaglandin E2 ameliorates acute liver failure via attenuation of cell death and regulation of macrophage polarization

  2021cites this paper
• Identification of hub genes and pathways in nonalcoholic steatohepatitis by integrated bioinformatics analysis

  2021cites this paper
• Delineating tesamorelin response pathways in HIV-associated NAFLD using a targeted proteomic and transcriptomic approach

  2021cites this paper
• Gut Akkermansia muciniphila ameliorates metabolic dysfunction-associated fatty liver disease by regulating the metabolism of L-aspartate via gut-liver axis

  2021cites this paper
• Pirfenidone modifies hepatic miRNAs expression in a model of MAFLD/NASH

  2021cites this paper
• 3D human nonalcoholic hepatic steatosis and fibrosis models

  2021cites this paper
• TGF Beta Induces Vitamin D Receptor and Modulates Mitochondrial Activity of Human Pancreatic Cancer Cells

  2021cites this paper